Skip to Main Content Menu Search Site

AminoX: Making Biologics Safer with Synthetic Biology and Advanced Chemistry

Enhancing safety and potency of protein drugs using non-standard amino acids and synthetic biology hacks of the ubiquitous protein synthesis process

Interested in AminoX?

The team is currently seeking pharmaceutical partners looking to improve the therapeutic index of their biologics, investors, and collaborators to continue to de-risk and expand its technology and ultimately launch a startup.


Synthetic Biology and Living Cellular Devices

Technology Development Team
Key Features
  • Development of safer protein drugs with higher therapeutic indices
  • Ability to incorporate an unprecedented variety of non-standard amino acids (nsAAs) into protein drugs
  • Computationally enhanced high-throughput screening process accelerating the identification of optimal nsAA-containing protein drugs
Close menu